SREBF1 and metabolic dysfunction-associated steatotic liver disease: However, when additionally simulating increased SREBP-1c expression, the rates of lipogenesis and triglyceride synthesis increased to 2.31 and 2.05 times the MH rate respectively (Fig 5A and 5F), consistent with in vivo NAFLD [2, 36, 71, 72].